The CLDN1 gene gives your body instructions for making claudin 1, a protein that helps seal the spaces between skin and other lining cells so they form a protective barrier. This gene helps your body keep moisture in and keep irritants, germs, and bile in the right place. If both copies of the CLDN1 gene do not work properly, a person can develop a rare inherited condition that may cause dry, scaly skin and liver problems. CLDN1 is mainly known in medical genetics rather than public culture.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, the parts of cells that do the work. Other genes mainly help control when certain processes happen, where they happen, and how strongly they are carried out. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. More on this topic is available in the LearnHub.
Overview
CLDN1Gene function
What if the gene works
The CLDN1 gene helps make a protein that seals neighboring cells together. This supports strong barriers in the skin and other linings, helping control water loss and keep out irritants and germs.
Risk
What if the gene does not work
More disruptive variants in the CLDN1 gene can cause a rare condition with skin scaling from birth and liver disease affecting bile flow. Milder or different variants may change when symptoms begin, how severe they are, and which features appear.
Treatment
What does that mean for your treatment
No CLDN1-specific treatment or drug selection approach is currently established for people with pathogenic variants in the CLDN1 gene. Care is based on the person's symptoms, while CLDN1 is being studied as a possible biomarker and drug target in some cancers and in hepatitis C entry blocking research.
Conditions associated with CLDN1
Gene function
What if the gene works
Your skin and many body linings need CLDN1 to keep neighboring cells closely connected. This gene helps build tight junctions, the seals that limit what can slip between cells. Understanding how the CLDN1 gene supports the skin barrier and other body linings makes its day-to-day role easier to picture.
The CLDN1 gene helps neighboring cells form tight junctions, which are seal-like contacts along their edges. These junctions help create smooth, continuous layers in the skin and other body linings.
Its protein helps control what passes through the tiny spaces between cells. This supports water balance and helps keep useful substances in place while limiting unwanted leakage.
CLDN1 also supports cell polarity (the way a cell keeps its top and bottom sides organized). That orderly layout helps protective body surfaces work in a stable, coordinated way.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and the way the body reacts to environmental influences. Many do not produce any noticeable effects and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene works enough to contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CLDN1 gene usually affect how much claudin-1 reaches the cell edge and how well it helps form tight junctions, the seals between neighboring cells. CLDN1 gene variant effects on protein function can range from milder changes that leave some protein activity to more severe variants that make the protein too short, unstable, or absent. When the loss is greater, the linked condition often appears earlier or with more pronounced features.
How variants are linked to conditions
Pathogenic variants in the CLDN1 gene cause neonatal ichthyosis with sclerosing cholangitis syndrome, so the link between CLDN1 gene variants and this rare skin and liver condition is well established. People with this diagnosis often have dry, scaly skin from infancy and may also develop sparse hair and bile duct disease that can affect liver health. Finding a pathogenic variant in the CLDN1 gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common across the general population. Most do not have a direct effect on health and instead represent natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when multiple genes and environmental influences are involved. In some situations, though, a single well understood variant in a particular gene can be enough to establish a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the CLDN1 gene itself. If you have a CLDN1 change on genetic testing or a family history of a related condition, a doctor or genetic counselor can help explain what it may mean for you.
Inheritance of CLDN1 variants
Variants in the CLDN1 gene linked to CLDN1-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one altered copy from each parent. Parents who each carry one CLDN1 gene variant are often unaffected themselves, but with each pregnancy there is a 25% chance of having a child with the condition, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. In families asking how CLDN1 gene variants are inherited, this is the established pattern.
What does my CLDN1 result mean for my family?
For CLDN1, the best-known related condition is inherited in a recessive pattern. This usually means parents can be healthy carriers, and brothers or sisters may also be affected or be carriers. Other relatives on both sides of the family may carry the same gene change, especially if there is a family history of similar skin or liver problems.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the CLDN1 gene, a lab can analyze DNA from blood, saliva, or a cheek swab. CLDN1 genetic testing for skin and liver symptoms reads the gene for spelling changes or missing pieces. Results may confirm a relevant variant, find none, or identify a variant whose meaning is still unclear.
When should I consider getting a genetic test?
Consider CLDN1 testing if a baby or child has very dry, scaly skin from birth together with unexplained liver or bile duct problems, or if this rare condition runs in the family. Testing can help confirm whether CLDN1 is the cause and clarify the chance for future children.
A genetic result is only one part of your health story
Genetic results can provide valuable insight, but how much they explain depends on the condition and on the kind of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results may help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, broken down, moved through the body, or how strongly it acts at its target. This helps explain why the same medication works well for one person, has less effect in another, or causes more side effects in someone else. These differences are common and are one reason treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics is the area of study focused on how genetic differences affect response to medications. It examines links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. This understanding can support treatment decisions that are more informed and more personalized. You can read more about this topic in the LearnHub.
Drugs influenced by the CLDN1 gene
When should I seek medical advice?
There is no broadly confirmed role for this gene in guiding medication choice or dose at this time, so questions about medicines are best discussed with your doctor. It is a good idea to seek medical advice before starting or changing treatment, or sooner if you notice side effects or your symptoms are getting worse.
History
CLDN1 entered the scientific literature in 1998, when researchers identified claudin proteins as key parts of the structures that seal neighboring cells together. From these first observations, research expanded steadily. This discovery helped shift ideas about how body barriers are built, because scientists could now link specific genes to the cell lining seen under the microscope. In the years that followed, CLDN1 drew further attention when inherited variants were connected to a rare condition affecting the skin, hair, eyes, and liver. It later became widely studied again after work showed that CLDN1 also played a part in hepatitis C research, giving the gene a place in both basic biology and medical genetics.